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Background: Digital ischemia is associated with several rheumatologic disorders and is often difficult to treat. Symptoms and
sequelae can include pain, disability, need for amputation, and poor quality of life.
Methods: Patients diagnosed with digital ischemia were referred for an ultrasound-guided axillary nerve block using liposomal
bupivacaine (Exparel, Pacira Pharmaceuticals). The primary outcome measure was radial and ulnar artery diameter preprocedure
and postprocedure. Doppler waveform analyses were performed to measure arterial diameter and blood flow velocity. The
QuickDASH questionnaire was administered to evaluate upper extremity function and perceived disability.
Results: Mean radial and ulnar artery diameters increased from 0.19 cm and 0.16 cm to 0.23 cm and 0.20 cm, respectively, 1
hour postprocedure. Concomitant increases in blood flow velocities and hand temperature and lower pain scores were also
noted. Although pain generally returned to baseline after 1 week, QuickDASH symptom/disability scores improved at 30 days,
and 2 patients’ ischemic symptoms resolved spontaneously during the study period in the absence of other interventions.
Conclusion: Data regarding chemical sympathectomy using regional anesthesia are limited at this time. Our experience
suggests a potential role in the treatment and evaluation of digital ischemia. Patients with digital ischemia from rheumatologic
conditions appeared to have a greater benefit from a chemical sympathectomy than patients whose conditions had an
atherosclerotic or anatomic etiology. Even when the vasodilatory effects are transient, such an intervention may be useful when
a more permanent option such as surgical sympathectomy is being considered. Liposomal bupivacaine is only approved for
surgical infiltration at this time.
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INTRODUCTION
Secondary Raynaud phenomenon (RP) may lead to
digital ischemia in the setting of connective tissue disease,
with progressive systemic sclerosis or scleroderma being
the most common rheumatologic diagnosis.1-4 Although
other etiologies of digital ischemia exist, such as trauma,
severe peripheral vascular disease, and thrombotic or
vasoocclusive disorders, we limit the scope of this discus-
sion primarily to digital ischemia secondary to RP.
Digital ischemia secondary to RP is often difficult to treat
and results in poor quality of life. Conservative therapy and
medical management, including vasodilating agents and
calcium channel blockers, are minimally effective in the
treatment of RP.5,6 A paucity of evidence-based data is
available on invasive techniques such as stellate ganglion
blocks, and instances of block failure, limited duration of
effect, and the need for multiple repeat procedures are not
uncommon.3 Alternatives such as botulinum toxin injection,
spinal cord stimulation, and surgical sympathectomy may
be undesirable first-line measures because of their associ-
ated cost or invasive nature.3 If digital ischemia is
inadequately treated, pain, digital ulcers, infection, and
gangrene may develop, resulting in disability and the need
for amputation.
Regional anesthesia techniques, such as brachial plexus
blocks, cause a local anesthetic–induced blockade of
sympathetic fibers and have been used to treat digital
ischemia from a variety of etiologies.1-4,7-9 While perineural
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blockade results in the simultaneous benefits of vasodilation
and analgesia, data regarding local anesthetic–induced
sympathectomy characteristics are limited at this time.
Liposomal bupivacaine (Exparel, Pacira Pharmaceuticals)
is an encapsulated formulation of bupivacaine designed for
slow, continuous release.10,11 Given the potential for
prolonged vasodilation and analgesia, we sought to
investigate these properties in patients whose symptoms
persisted despite medical management and conservative
measures. Liposomal bupivacaine is only approved by the
US Food and Drug Administration for wound infiltration;
perineural use is considered off-label and should be
reserved for investigational use.10,11
METHODS
This study was approved by the Ochsner Institutional
Review Board and registered on clinicaltrials.gov (identifier
NCT02374320) prior to patient enrollment. Risks, benefits,
and alternatives were explained to patients prior to
obtaining written informed consent.
Patients with digital ischemia unresponsive to medical
management were invited to participate in the study. The
exclusion criteria were refusal, local anesthetic allergy, and
preexisting neurologic deficits of the upper extremity. Our
primary outcome measure was radial and ulnar artery
diameters before and after the block procedure. Numerical
rating scale (NRS) pain scores—ranging from 0 (absence
of pain) to 10 (worst pain imaginable)—along with hand
temperature, blood flow velocity, presence of a radial
pulse, and block onset characteristics were secondary
outcomes. The QuickDASH questionnaire (used with
permission from the Institute for Work & Health), an
abbreviated version of the Disability of the Arm, Shoulder,
and Hand (DASH) outcome measure, was administered to
every patient at baseline and weekly for 4 weeks. The
QuickDASH is a valid and reliable instrument for measuring
physical function and symptoms in patients with disorders
of the upper limbs in a wide variety of patient popula-
tions.12,13 The QuickDASH yields a disability/symptom
score that ranges from 0-100, with 0 indicating no
perceived disability and 100 indicating poor function.
Patients with bilateral ischemic digits were eligible to enroll
in the study a second time to treat the contralateral hand
30 days after the initial block procedure.
Radial and ulnar artery diameter and blood flow
velocities were measured at baseline and 60 min after
the nerve block with a Doppler ultrasound system and a 9-
3 MHz linear transducer (Philips iE33 L9-3 transducer).
Velocities were measured using pulse-wave Doppler, and
a marker was used to indicate the site of initial transducer
placement to ensure that subsequent scans were per-
formed at the same location. An adhesive temperature
probe was placed on the ischemic hand prior to the nerve
block. NRS pain scores, hand temperature, capillary refill
time, and the presence of a radial pulse before and after
the block were recorded.
All blocks were performed by a single staff anesthesiol-
ogist (J.R.S.) with expertise in ultrasound-guided regional
anesthesia. The axillary block site was selected (instead of
other potential sites such as the stellate ganglion) because
of the ease of ultrasonographic visualization and absence
of pulmonary or respiratory complications. The superficial
and compressible nature of the site poses minimal
bleeding risks, even in anticoagulated patients. Further-
more, because of the complexity of the sympathetic
outflow in the cervicothoracic region, an axillary block is
more likely to result in a more complete sympathetic block
than a stellate ganglion block.1,2 After administration of
intravenous sedation and skin preparation with chlorhex-
idine gluconate/alcohol (Chloraprep), an S-Nerve Ultra-
sound System L253 13-6 MHz probe (SonoSite) was
placed in the axillary crease, and the median, radial, ulnar,
and musculocutaneous nerves were identified. A 22-
gauge, 5-cm Stimuplex needle (B. Braun Medical, Inc.)
was inserted using an in-plane technique, and 5 mL of
1.3% liposomal bupivacaine was injected around each
nerve for a total of 20 mL.
After the block procedure, a research assistant assessed
block onset characteristics in the various nerve distributions
of the arm via pinprick at 10-, 20-, 30-, and 60-min intervals.
The onset of motor block was assessed using thumb
opposition (median nerve), thumb adduction (ulnar nerve),
thumb abduction (radial nerve), and flexion of the elbow
(musculocutaneous nerve). A score of 2 was recorded if the
patient had baseline strength or sensation to pinprick, while
scores of 1 and 0 indicated decreased and absent strength
or sensation, respectively.
Statistical Analysis
Categorical variables are presented as counts and
percentages, with differences between the groups assessed
using the chi-square test or Fisher exact test. The Shapiro-
Wilk and Kolmogorov-Smirnov tests were performed to
determine normality of data. Continuous variables with
nonnormal distributions were assessed by the Wilcoxon
rank-sum test. We considered P values <0.05 statistically
significant.
RESULTS
Thirteen patients were enrolled in the study, and 1
returned for a second block on the contralateral hand.
One patient was in the intensive care unit with severe
vasopressor-induced ischemic injury in all 4 extremities and
was withdrawn from the study because of prolonged
mechanical ventilation and amputations of all 4 extremities.
Only the block characteristics for this patient were included
in the analysis.
The majority of patients (78.6%) were female, and the
mean age was 50.7 years. Block characteristics are
presented in Table 1. One hour after the procedure, the
mean radial and ulnar artery diameters increased from 0.19
cm and 0.16 cm to 0.23 cm and 0.20 cm, respectively. We
found no difference in the ability to palpate a radial artery
pulse before or after the block. Prior to the block, 57.1% of
patients had impaired capillary refill (>2 seconds) com-
pared to 23.1% postblock. A statistically significant
increase in hand temperature was also noted (P<0.01).
Percentage increases of 21%, 132%, and 79% were
identified in radial artery diameter, peak systolic velocity,
and mean diastolic velocity, along with concomitant
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percentage increases of 25%, 66%, and 122% in ulnar
artery diameter, peak systolic velocity, and mean diastolic
velocity, respectively. Significant differences were identi-
fied in the mean NRS scores preblock and postblock,
although the 30-day mean NRS score was similar to the
mean baseline score. Figure 1 shows a Doppler study from
one of our patients. These waveform findings were not
uncommon and were observed in most patients. Hand
color and appearance were generally improved after the
block procedure compared to baseline (Figure 2). The
onset and progression of sensory and motor block are
illustrated in Figure 3.
The QuickDASH questionnaire was administered at
baseline and weekly for 1 month. A statistically significant
improvement in QuickDASH symptom/disability scores was
identified at 1 month compared to baseline (P¼0.03, Table
2).
Medical records for every patient were reviewed at least 6
months after enrollment, and patients were contacted via
telephone (as needed) to determine the status of their
digital ischemic symptoms as well as their overall health and
functional status (Table 3). Interestingly, 2 patients’ ische-
mic issues (patients 3 and 5) have resolved to date with the
block alone in the absence of changes in medical
management or other interventions. A third patient (patient
9) had resolution of her ischemic symptoms shortly after her
block procedure; she also had changes in her medical
management instituted in proximity to the study interven-
tion, so it is unclear if the improvement resulted from the
block, changes in medication, or a combination thereof. The
other 10 patients had persistent ischemic symptoms at the
conclusion of the study period. For 8 of these 10 patients,
we recommended referral to a hand surgeon for a distal
peripheral sympathectomy procedure. Three patients (pa-
tients 1, 2, and 13) were deemed surgical candidates and
underwent surgery on the affected hand (1 of the 3
underwent a partial finger amputation because of the onset
of gangrene prior to the surgical sympathectomy), and the
remaining 5 (patients 4, 8, 10, 11, and 12) declined the
referral or surgery, were deemed poor surgical candidates,
or received other therapies (continued medical manage-
ment, hyperbaric oxygen therapy, or referral to a pain
specialist). At the time of this writing, 3 patients had died.
We observed no study-related adverse events or complica-
tions.
DISCUSSION
We evaluated the vasodilatory and analgesic effects of a
perineural injection in patients with digital ischemia. Based
Table 2. QuickDASH Symptom/Disability Scoresa
Patient Numberb,c
Baseline
QuickDASH
Symptom/
Disability Score
30-Day
QuickDASH
Symptom/
Disability Score
1 59.1 54.6
2 68.2 68.2
3 20.5 11.4
4 84.1 100
5 88.7 45.5
6 100 100
7 59.1 47.7
8 84.1 72.7
10 81.8 11.4
11 79.5 20.5
12 88.6 68.2
13 59.1 45.5
Mean QuickDASH
symptom/disability
score (all patients) 72.7 53.8d
aQuickDASH symptom/disability scores range from 0-100; a score of 0
indicates absence of disability and excellent function, whereas a score of
100 suggests a high degree of disability and poor function.
bQuickDASH results were missing for patient 9.
cPatient 14 was excluded from analysis because of prolonged mechanical
ventilation and subsequent upper extremity amputation.
dStatistically significant difference (P¼0.03).
Table 1. Block Characteristics
Variable Preblock Postblock P Value
Mean NRS pain score (0-10) 6.0 0.4 <0.01
Mean 30-day NRS pain score (0-10) 5.2 NS
Patients with radial artery pulse present, % 78.6 84.6 NS
Patients with capillary refill >2 seconds, % 57.1 23.1 0.03
Mean hand temperature, 8C 26.3 29.6 <0.01
Mean radial artery diameter, cm 0.19 0.23 <0.01
Mean radial peak systolic velocity, cm/s 47.4 109.9 <0.01
Mean radial mean diastolic velocity, cm/s 12.9 23.1 NS
Mean ulnar artery diameter, cm 0.16 0.20 <0.01
Mean ulnar peak systolic velocity, cm/s 48.5 80.5 <0.01
Mean ulnar mean diastolic velocity, cm/s 9.6 21.3 <0.01
NRS, numerical rating scale; NS, not significant.
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on Doppler waveform analysis and improvements in
capillary refill and hand appearance, we can conclude that
a perineural injection of liposomal bupivacaine results in a
temporary chemical sympathectomy. The durations of
sympathectomy, vasodilation, and analgesia are unknown
but may be longer than the anticipated duration of liposomal
bupivacaine.7,10,11
Multiple clinically and statistically significant changes
were noted immediately after the block procedure. NRS
pain scores decreased dramatically, with 12 of 13 patients
reporting resolution (0/10) of pain. The increases in hand
temperature as well as in nearly all hemodynamic param-
eters combined with the improvements in capillary refill time
indicate improvements in microcirculation and macrocircu-
lation. In summary, these changes are consistent with a
local anesthetic–induced chemical sympathectomy and
vasodilation.
Liposomal bupivacaine may be beneficial in the
treatment and evaluation of digital ischemia. Patients
who respond favorably based on Doppler waveform
studies and clinical evaluation may warrant a referral to
a hand surgeon for a distal peripheral sympathectomy
procedure. While it is unknown if a positive response to a
peripheral nerve block predicts surgical outcomes,
performance of a peripheral nerve block prior to surgery
is a common practice and has been advocated by
multiple investigators and experts in the field.1-4,14-16 An
added potential benefit of local anesthetic–induced
sympathectomy is that it may aid in healing of ulcers
prior to surgery.1,15 Furthermore, 2 patients had resolu-
tion of their ischemic symptoms during the study period
despite previous failure of conservative measures and
medical management.
Figure 1. Doppler waveform analysis of a patient’s radial
artery. The skin was marked to identify the site of initial
transducer placement to ensure that the subsequent
measurements were recorded at the same location. A poor
waveform appearance was observed at baseline (A).
Increases in vessel size, peak systolic velocity, and mean
diastolic velocity as well as improvement in waveform
appearance were noted 1 hour after the block procedure
(B).
Figure 2. Photographs of a patient’s hand prior to (A) and 1
hour after (B) the study intervention. Cyanosis of all digits
and a small digital ulcer on the second digit are visible prior
to the block. (Color photographs are available online at
www.ochsnerjournal.org/toc/ochs/16/4 in the Original Re-
search section.)
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While a formal discussion of distal peripheral sympa-
thectomy surgery is beyond the scope of this paper, this
technique should be considered an early treatment option
for patients suffering from digital ischemia. However,
many providers view surgical sympathectomy as a last
resort in the management of digital ischemia. As the
disease progresses, patients are more likely to develop
ulcers, infection, and gangrene in addition to near-
constant pain and poor quality of life.17 Momeni et al
reported that patients suffered ischemic pain for an
average of 9.6 years and that digital ulcers were present
for an average of 10.1 months prior to referral for
surgery.17 We propose that a peripheral nerve block be
part of the initial evaluation for patients with digital
ischemia unresponsive to medical management or con-
servative measures. Patients who respond favorably in
terms of Doppler studies and clinical evaluation should
subsequently be referred to a hand specialist for possible
surgical sympathectomy early in the course of the
disease—before the onset of digital ulcers, infection, or
gangrene.
This investigation has several limitations, the first being
the absence of a control or placebo group. Patients were
referred to participate in the study because their digital
ischemia was unresponsive to medical management and
conservative measures. We considered exposing patients
to the risks (albeit minor) of a sham peripheral nerve block
or placebo to be unethical, given the failure of previous
therapies and the unremitting nature of ischemic pain.
Another limitation of our study is the lack of comparison to
alternative therapies such as single-injection brachial
plexus blocks with nonliposomal local anesthetics, in-
dwelling perineural catheters, stellate ganglion blockade,
botulinum toxin injection, or spinal cord stimulation.
Comparing these approaches, which vary in invasiveness
and cost, was beyond the scope of the investigation (to
evaluate the vasodilatory properties of liposomal bupiva-
caine) and could be the subject of future investigations.
Last, our study was likely underpowered to detect rare
adverse events. Further research is warranted to deter-
mine the safety and role of liposomal bupivacaine in the
treatment of digital ischemia.
Figure 3. Progression of sensory and motor block. The graphs represent the musculocutaneous nerve (A), median nerve (B),
radial nerve (C), and ulnar nerve (D). Data are presented as percentage of patients with absence of sensation or motor
function in the respective nerve distribution at the specified times after the block procedure.
Liposomal Bupivacaine Sympathectomy
454 Ochsner Journal
CONCLUSION
An axillary nerve block with liposomal bupivacaine
(Exparel) produces a local anesthetic–induced chemical
sympathectomy that results in analgesia and vasodila-
tion in patients with digital ischemia. The effect, however,
was generally transient. Patients who respond favorably
to a peripheral nerve block should be considered for
distal peripheral sympathectomy surgery, preferably
early in the course of the disease. Liposomal bupiva-
caine is only approved for surgical wound infiltration at
this time.
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